Incyte Q1 2026 revenue rises 21% to $1.27 billion; 2026 guidance reaffirmed
Incyte reported first-quarter 2026 total revenue of $1.27 billion, up 21% from the prior year, with GAAP diluted EPS of $1.47 versus $0.80 a year earlier. The company reaffirmed all of its 2026 financial guidance categories and said cash, cash equivalents and marketable securities reached $4.0 billion as of March 31, 2026.
Key points
- Total revenue was $1.27 billion, up 21% from $1.05 billion in Q1 2025; total net sales were $1.10 billion, up 20%.
- GAAP net income was $303.3 million versus $158.2 million, and GAAP diluted EPS was $1.47 versus $0.80.
- Jakafi net sales rose 7% to $758 million; GAAP cost of sales rose 43% to $104.5 million.
- Full-year 2026 guidance was reaffirmed, including total net sales of $4,770 million to $4,940 million; Suketu Upadhyay was named Chief Financial Officer effective May 4, 2026.
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 28, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.